Europe Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
Europe Pharmaceuticals Market @Summary, Competitive Analysis and Forecast to 2026
SUMMARY
Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The European pharmaceuticals market had total revenues of $337.9 billion in 2021, representing a compound annual growth rate (CAGR) of 4.7% between 2016 and 2021.
- An aging population in many countries in Europe has helped to drive demand for pharmaceutical products due to greater treatment requirements for age-associated diseases such as diabetes and cardiovascular diseases.
- Germany, France, and the UK are the leading European pharmaceutical markets, with a 23.6%, 21.5%, and 9.0% share of the market, respectively, in 2021.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Europe
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts
- What was the size of the Europe pharmaceuticals market by value in 2021?
- What will be the size of the Europe pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the Europe pharmaceuticals market?
- How has the market performed over the last five years?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. How have leading players responded to the COVID-19 pandemic?
7.5. Are there any threats toward leading players?
8 COMPANY PROFILES
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Johnson & Johnson
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. How have leading players responded to the COVID-19 pandemic?
7.5. Are there any threats toward leading players?
8 COMPANY PROFILES
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Johnson & Johnson
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Europe pharmaceuticals market value: $ billion, 2016–21
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Europe pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Europe pharmaceuticals market share: % share, by value, 2021
Table 5: F. Hoffmann-La Roche Ltd: key facts
Table 6: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 7: F. Hoffmann-La Roche Ltd: Key Employees
Table 8: Novartis AG: key facts
Table 9: Novartis AG: Annual Financial Ratios
Table 10: Novartis AG: Key Employees
Table 11: Novartis AG: Key Employees Continued
Table 12: Johnson & Johnson: key facts
Table 13: Johnson & Johnson: Annual Financial Ratios
Table 14: Johnson & Johnson: Key Employees
Table 15: Johnson & Johnson: Key Employees Continued
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: Annual Financial Ratios
Table 18: Pfizer Inc.: Key Employees
Table 19: Pfizer Inc.: Key Employees Continued
Table 20: Europe size of population (million), 2017–21
Table 21: Europe gdp (constant 2005 prices, $ billion), 2017–21
Table 22: Europe gdp (current prices, $ billion), 2017–21
Table 23: Europe inflation, 2017–21
Table 24: Europe consumer price index (absolute), 2017–21
Table 25: Europe exchange rate, 2017–21
Table 1: Europe pharmaceuticals market value: $ billion, 2016–21
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Europe pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Europe pharmaceuticals market share: % share, by value, 2021
Table 5: F. Hoffmann-La Roche Ltd: key facts
Table 6: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 7: F. Hoffmann-La Roche Ltd: Key Employees
Table 8: Novartis AG: key facts
Table 9: Novartis AG: Annual Financial Ratios
Table 10: Novartis AG: Key Employees
Table 11: Novartis AG: Key Employees Continued
Table 12: Johnson & Johnson: key facts
Table 13: Johnson & Johnson: Annual Financial Ratios
Table 14: Johnson & Johnson: Key Employees
Table 15: Johnson & Johnson: Key Employees Continued
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: Annual Financial Ratios
Table 18: Pfizer Inc.: Key Employees
Table 19: Pfizer Inc.: Key Employees Continued
Table 20: Europe size of population (million), 2017–21
Table 21: Europe gdp (constant 2005 prices, $ billion), 2017–21
Table 22: Europe gdp (current prices, $ billion), 2017–21
Table 23: Europe inflation, 2017–21
Table 24: Europe consumer price index (absolute), 2017–21
Table 25: Europe exchange rate, 2017–21
LIST OF FIGURES
Figure 1: Europe pharmaceuticals market value: $ billion, 2016–21
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Europe pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Europe, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Europe, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Europe, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2021
Figure 10: Europe pharmaceuticals market share: % share, by value, 2021
Figure 1: Europe pharmaceuticals market value: $ billion, 2016–21
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Europe pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Europe, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Europe, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Europe, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2021
Figure 10: Europe pharmaceuticals market share: % share, by value, 2021
